Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXS4EL
|
||||
| Drug Name |
6-{1-[2-(2-Methyl-quinolin-5-yloxy)-ethyl]-piperidin-4-ylmethyl}-4H-benzo[1,4]oxazin-3-one
|
||||
| Synonyms |
CHEMBL180700
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C21H23N3O4
|
||||
| Canonical SMILES |
O=C1COc2ccc(OCCNCCCOc3cccc4[nH]ccc34)cc2N1
|
||||
| InChI |
InChI=1S/C21H23N3O4/c25-21-14-28-20-6-5-15(13-18(20)24-21)26-12-10-22-8-2-11-27-19-4-1-3-17-16(19)7-9-23-17/h1,3-7,9,13,22-23H,2,8,10-12,14H2,(H,24,25)
|
||||
| InChIKey |
YORRFXCSZXGULE-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.